“…For example, even if most cohorts included only older adults aged 65 years and older, some also tested middle-aged or even younger adults, with various proportions [20,22,24,25,27,28,34,36]. Age is known to increase the risks of both cognitive decline [18] and hypovitaminosis D [1][2][3]54]. It seems therefore crucial to focus on a homogeneous age group while assessing the neurological effects of vitamin D, especially since it has been suggested that the neuroprotective effects of vitamin D increase with the advance in age [4].…”